昆船智能(301311.SZ):本次國內加徵關稅對公司現有業務的影響有限
格隆匯4月8日丨昆船智能(301311.SZ)公佈,近日,美國政府發佈所謂“對等關稅”的政策,徵收更高關稅,引發市場高度關注。昆船智能技術股份有限公司(以下簡稱“公司”)作爲央企控股的上市公司,積極響應實際控制人號召,持續密切關注全球貿易政策,經初步評估,本次美國加徵關稅,對公司可能會產生的影響及相關應對措施如下:
公司近年來採取一系列措施持續加大研發投入力度、大力發展國產化替代,僅有部分器件採購自北美地區,公司供應鏈較穩定,美國加徵關稅對公司產品出口影響較小,因此,本次國內加徵關稅對公司現有業務的影響有限。鑑於此,本輪美國加徵關稅對公司的整體生產經營影響有限,公司生產經營一切正常。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.